Table 2.
The results of the logistic regression analysis of clinical risk factors for WMHs.
| B | SE | Walds | P | OR (95%CI) | |
|---|---|---|---|---|---|
| Sex (Male) | 0.191 | 0.543 | 0.124 | 0.724 | 1.211 (0.418–3.508) |
| Age | 0.044 | 0.032 | 1.940 | 0.164 | 1.045 (0.982–1.111) |
| Education | −0.100 | 0.064 | 2.462 | 0.117 | 0.905 (0.799–1.025) |
| Hypertension | 1.779 | 0.534 | 11.106 | 0.001 | 5.925 (2.081–16.869) |
| Diabetes | 1.920 | 0.987 | 3.785 | 0.052 | 6.818 (0.986–47.148) |
| Hyperlipidemia | 0.082 | 0.689 | 0.014 | 0.905 | 1.086 (0.281–4.190) |
| Smoking | 0.218 | 0.635 | 0.118 | 0.731 | 1.244 (0.358–4.319) |
| Drinking | 0.428 | 0.571 | 0.562 | 0.454 | 1.534 (0.501–4.700) |
| TCH | 0.169 | 0.215 | 0.621 | 0.431 | 1.184 (0.778–1.804) |
| TG | −0.227 | 0.233 | 0.949 | 0.330 | 0.797 (0.505–1.258) |
| GLU | −0.199 | 0.219 | 0.824 | 0.364 | 0.820 (0.534–1.259) |
| hsCRP | 0.175 | 0.117 | 2.242 | 0.134 | 1.191 (0.947–1.496) |
| LP–PLA2 | 0.013 | 0.006 | 4.824 | 0.028 | 1.013 (1.001–1.024) |
Significant differences are indicated in bold. WMHs, white matter hyperintensities; B, regression coefficient; Walds, Wald test; OR, odds ratio; TCH, total cholesterol; TG, triglyceride; GLU, glucose; hsCRP, hypersensitive C-reactive protein; Lp-PLA2, lipoprotein-associated phospholipase A2.